InvestorsHub Logo
Followers 1
Posts 210
Boards Moderated 0
Alias Born 03/27/2014

Re: TomP1 post# 70752

Thursday, 07/28/2016 1:22:53 PM

Thursday, July 28, 2016 1:22:53 PM

Post# of 462060
You are correct. The critics have always said 98% of companies such as AVXL will not be successful in the Alzheimer's arena. The recent stats show a decline which likely puts Anavex in with that group. It is no longer attractive as a buyout or partnership. The "miracle drug" label was damaged, in the eyes of most. I see the stock settling down to the $2.75-$3.50 range for quite a while. Some are still buying on dips as the stock drops but at this point that is a lost cause. Ask those who ran it up from $4.08 to $5.26 yesterday or $3.75 to $4.40 today. Sorry folks the "pop" is gone.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News